Free Trial

Rocket Pharmaceuticals (RCKTW) News Today

Rocket Pharmaceuticals logo
$0.03 0.00 (-10.57%)
As of 05/28/2025 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Why is Rocket Pharmaceuticals Dropping Today?

Rocket Pharmaceuticals, Inc. (RCKTW) shares fell today after news of a patient death prompted the U.S. Food and Drug Administration to pause and place a clinical hold on the company’s mid‐stage gene therapy trial for Danon disease, compounding pressure from a recent analyst downgrade.

  • Retail investors reportedly turned bullish on the stock after the initial sell‐off, suggesting potential support at lower levels.
  • Short interest remains minimal, with a days‐to‐cover ratio of 0.0 days, pointing to limited short‐squeeze dynamics.
  • Rocket was highlighted among “trending tickers,” boosting the company’s market visibility.
  • The firm issued a Phase 2 clinical update for RP-A501 in Danon disease, underlining continued commitment to its gene therapy pipeline.
  • A participant’s death in the RP-A501 trial triggered an FDA pause and clinical hold, raising safety and regulatory concerns.
  • Needham downgraded Rocket Pharmaceuticals, adding to selling pressure on the stock.
  • The share price plunged in pre‐market trading following the trial hold, reflecting investor anxiety over the program’s future.
Posted 11h agoAI Generated. May Contain Errors.

RCKTW Latest News

Rocket posts net loss in first quarter
Rocket Lab nets major Pentagon contract
Rocket Lab (RKLB) Shares Climb 5% Ahead of Quarterly Earnings
Rocket Pharmaceuticals initiated with an Outperform at Wedbush
Rocket Pharmaceuticals announces $150M common stock offering
Rocket Pharmaceuticals Advances Genetic Therapies Pipeline
Bank of America Securities Remains a Buy on Rocket Pharmaceuticals (RCKT)
Get Rocket Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for RCKTW and its competitors with MarketBeat's FREE daily newsletter.

RCKTW Media Mentions By Week

RCKTW Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

RCKTW
News Sentiment

-0.01

0.87

Average
Medical
News Sentiment

RCKTW News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

RCKTW Articles
This Week

12

2

RCKTW Articles
Average Week

Get Rocket Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for RCKTW and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:RCKTW) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners